Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Basaglar. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Insulin glargine.
Level 1 evidence
Acebutolol
The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetazolamide
The risk or severity of hypoglycemia can be increased when Acetazolamide is combined with Insulin glargine.
Level 1 evidence
Acetyl sulfisoxazole
The risk or severity of hypoglycemia can be increased when Acetyl sulfisoxazole is combined with Insulin glargine.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.
Level 1 evidence
Albuterol
The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Salbutamol.
Level 1 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin glargine.
Level 1 evidence
Alogliptin
The risk or severity of hypoglycemia can be increased when Alogliptin is combined with Insulin glargine.
Level 1 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin glargine.
Level 1 evidence
Amiloride
The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Amiloride.
Level 1 evidence
Aminosalicylic acid
The risk or severity of hypoglycemia can be increased when Aminosalicylic acid is combined with Insulin glargine.
Level 1 evidence
Amiodarone
The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.
Basaglar (Insulin Glargine) has 376 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Basaglar (Insulin Glargine) has 2 major, 360 moderate, and 14 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Basaglar. Always confirm against the full prescribing information.